[artículo] 
inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 350-356

Título :	A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments
Tipo de documento:	texto impreso
Autores:	Yvonne M. Greene, Autor ; Pierre N. Tariot, Autor ; Heather Wishart, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 350-356
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastornos cognitivos, Indanos - efectos adversos, Indios, Esclerosis múltiple, Agentes Nootrópicos, Piperidinas.
Resumen:	Cognitive dysfunction occurs in up to 65% of patients with multiple sclerosis (MS), but there is no effective treatment for the symptoms. The authors conducted a 12-week, open-pilot study to assess the efficacy and tolerability of donepezil HCl administered in patients with MS and cognitive impairment. Seventeen patients at a long-term care facility with Mini-Mental State Examination scores of ≤ 25 received 5 mg of donepezil HCl for a 4-week period, followed by 8 weeks of 10 mg of donepezil HCl.
Link:	./index.php?lvl=notice_display&id=31194

[artículo] A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments [texto impreso] / Yvonne M. Greene, Autor ; Pierre N. Tariot, Autor ; Heather Wishart, Autor . - 2023 . - pp. 350-356.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 3 (Junio) . - pp. 350-356

Palabras clave:	Trastornos cognitivos, Indanos - efectos adversos, Indios, Esclerosis múltiple, Agentes Nootrópicos, Piperidinas.
Resumen:	Cognitive dysfunction occurs in up to 65% of patients with multiple sclerosis (MS), but there is no effective treatment for the symptoms. The authors conducted a 12-week, open-pilot study to assess the efficacy and tolerability of donepezil HCl administered in patients with MS and cognitive impairment. Seventeen patients at a long-term care facility with Mini-Mental State Examination scores of ≤ 25 received 5 mg of donepezil HCl for a 4-week period, followed by 8 weeks of 10 mg of donepezil HCl.
Link:	./index.php?lvl=notice_display&id=31194